Arcalyst
rilonacept
Listed by Kiniksa Pharmaceuticals (UK), Ltd.
- Strength
- 160 mg/2mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Subcutaneous
What it contains
- Rilonacept 160 mg/2mL
FDA record
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Subcutaneous |
| Approval route | BLA — biologic licence |
| NDC code | 73604-914 |
| FDA application | BLA125249 |
| RxNorm concept | 763453 |
| Package sizes listed | 2 |
| Marketed since | February 2008 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.